Melanoma, Experimental
Recent clinical, regulatory, research and industry developments relating to this disease.
Cytokine-armed pyroptosis induces antitumor immunity against diverse types of tumors.
RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming.
Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade.
Meningeal lymphatic vessels regulate brain tumor drainage and immunity.
Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes8
- Nanoparticles3
- Cellular Reprogramming1
- Dendritic Cells1
- Diet, Ketogenic1
- Glucose1
- Immunotherapy1
- Inflammasomes1
- L-Lactate Dehydrogenase1
Leading journals6
- Nature communications6
- The Journal of clinical investigation2
- Cancer immunology research1
- Cell research1
- JCI insight1
- Journal for immunotherapy of cancer1
Leading researchers8
- Wang X3
- DeVito NC2
- Hanks BA2
- Holtzhausen A2
- Sun X2
- Theivanthiran B2
- Zhang J2
- Adams R1
Affiliations (unnormalised)6
- Duke Cancer Institute2
- Duke University2
- Johns Hopkins University School of Medicine2
- Lineberger Comprehensive Cancer Center2
- Affiliated Hospital of Guangdong Medical University1
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine1
Disease biology
Key proteins & gene products studied in this disease. Number shows shared papers.
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Disease profile
A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.
Experimental melanoma is an experimentally induced, melanin-producing tumor in animals used as a model for studying human melanoma. It is a research model rather than a naturally occurring human disease.
It is experimentally induced in animals. The supplied grounding does not support a natural aetiology beyond its intentional induction for research.
The literature grounding links this model to tumor microenvironment effects, signal transduction, macrophage activation, and cellular reprogramming. It is also co-studied with programmed cell death 1 receptor, B7-H1 antigen, and cytokines, indicating use in investigating immune and signaling pathways relevant to melanoma biology.
AI-generated summary grounded in MeSH. Informational only — not medical advice. Generated 2026-07-07.
Reference
Authoritative identity, definition & identifiers.
Experimentally induced tumor that produces MELANIN in animals to provide a model for studying human MELANOMA.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.